Grantham, Mayo, Van Otterloo & Co (GMO)
MDSO

Grantham, Mayo, Van Otterloo & Co (GMO)’s Medidata Solutions, Inc. MDSO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-549,200
Closed -$50.3M – 806
2019
Q3 		$50.3M Buy
+549,200
New +$50.2M 0.35% 53

Other funds holding MDSO

WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MDSO Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 549,200 shares — an estimated $50.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MDSO in Q3 2019 and held it in 1 quarter. The position peaked at $50.3M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 549,200 Medidata Solutions, Inc. shares in Q4 2019, an estimated $50.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Medidata Solutions, Inc. in Q3 2019 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Medidata Solutions, Inc. position peaked at $50.3M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.